Quarterly Financial Results (Tables)

12 Months Ended

Jun. 30, 2013

Summarized Quarterly Results of Continuing Operations [Abstract]

Schedule of Quarterly Financial Information

	First Quarter		Second Quarter		Third Quarter		Fourth Quarter (A)
Year ended June 30, 2013
Revenues	$	2,637.5	$	2,747.8	$	3,114.3	$	2,810.5
Costs of revenues	$	1,586.5	$	1,624.3	$	1,745.9	$	1,692.8
Gross profit	$	1,051.0	$	1,123.5	$	1,368.4	$	1,117.7
Net earnings from continuing operations	$	302.5	$	352.0	$	482.7	$	227.0
Basic earnings per share from continuing operations	$	0.63	$	0.73	$	1.00	$	0.47
Diluted earnings per share from continuing operations	$	0.62	$	0.72	$	0.99	$	0.47
	First Quarter		Second Quarter (B)		Third Quarter		Fourth Quarter
Year ended June 30, 2012
Revenues	$	2,510.9	$	2,570.7	$	2,910.9	$	2,623.6
Costs of revenues	$	1,500.4	$	1,513.7	$	1,618.2	$	1,582.0
Gross profit	$	1,010.5	$	1,057.0	$	1,292.7	$	1,041.6
Net earnings from continuing operations	$	300.4	$	372.8	$	450.2	$	256.2
Basic earnings per share from continuing operations	$	0.62	$	0.77	$	0.92	$	0.53
Diluted earnings per share from continuing operations	$	0.61	$	0.76	$	0.91	$	0.52

(A) Net earnings from continuing operations and diluted earnings per share from continuing operations includes the impact of a goodwill impairment charge related to ADP AdvancedMD, which decreased net earnings from continuing operations by $42.7 million and diluted earnings per share from continuing operations by $0.09.

(B) Net earnings from continuing operations and diluted earnings per share from continuing operations includes the impact of a gain on sale of assets related to the rights and obligations to resell a third-party management platform which increased net earnings from continuing operations by $41.2 million and diluted earnings per share from continuing operations by $0.08.